Results

Marizyme Inc.

04/16/2024 | Press release | Distributed by Public on 04/16/2024 05:05

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™